featured
Efficacy and Safety of Pioglitazone Add-on Therapy in Patients With Type 2 Diabetes Treated With Metformin and Dapagliflozin
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Diabetes, Obesity & Metabolism
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
A multicentre, double-blind, placebo-controlled, randomized, parallel comparison, phase 3 trial to evaluate the efficacy and safety of pioglitazone add-on therapy in type 2 diabetic patients treated with metformin and dapagliflozin
Diabetes Obes Metab 2024 Feb 29;[EPub Ahead of Print], S Lim, SH Lee, KW Min, CB Lee, SY Kim, HJ Yoo, NH Kim, JH Kim, S Oh, JC Won, HS Kwon, MK Kim, JH Park, IK Jeong, S KimFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.